| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3B | $4.1B | $3.8B | $3.7B | $3.1B | $0.7B | $0.6B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $0.6B | $0.5B | $0.4B |
| R&D Expense | — | — | — | — | — | — | $0.3B | $0.2B |
| SG&A Expense | $1.8B | $1.4B | $1.3B | $1.4B | $1.5B | $0.9B | $0.7B | $0.7B |
| Operating Income | $-0.4B | $0.7B | $0.6B | $-0.1B | $0.2B | $0.4B | $0.5B | $0.6B |
| Net Income | $-0.4B | $0.6B | $0.4B | $-0.2B | $-0.3B | $0.1B | $0.1B | $0.2B |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $2.39 | $1.31 | $2.69 |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $2.33 | $1.29 | $2.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.7B | $12.0B | $11.4B | $10.8B | $12.3B | $6.5B | $5.5B | $5.2B |
| Current Assets | $4.2B | $4.6B | $3.4B | $2.6B | $2.6B | $2.8B | $1.6B | $1.2B |
| Cash & Equivalents | $1.4B | $2.4B | $1.5B | $0.9B | $0.6B | $1.1B | $0.6B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.2B | $1.0B | $1.5B | $0.9B | $0.8B | $0.7B | $0.4B | $0.3B |
| Stockholders' Equity | $4.3B | $4.1B | $3.7B | $3.1B | $4.0B | $3.7B | $3.1B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.4B | $1.1B | $1.3B | $0.8B | $0.9B | $0.8B | $0.8B |
| Investing Cash Flow | $-1.5B | $-0.5B | $-0.2B | $-0.4B | $-5.2B | $-1.0B | $-0.2B | $-0.4B |
| Capital Expenditures | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | — | — |
| Financing Cash Flow | $-0.9B | $0.0B | $-0.3B | $-0.5B | $4.0B | $0.5B | $-0.3B | $-0.5B |